| « Elan en Biogen Idec initiëren eerste klinisch onderzoek TYSABRI in ... | Velcade®, Melphalan, and Prednisone Improves Survival of Patients ... » |
Human Genome shares fall on trial results report
09/04/08
Human Genome shares fall on trial results report
Link: http://www.forbes.com/feeds/ap/2008/09/03/ap5385158.html
Human Genome shares fall on trial results report Forbes, NY - Sep 3, 2008 The company reported Tuesday that a combination of the antibody mapatumumab and Velcade showed no incremental benefit for patients with multiple myeloma,
XML Feeds